Avac Event

Webinar: HIV – The Basics What You Need To Know, And Want to Know About HIV Cure Research

This webinar covered the basics of cure research. The webinar was led by Nicolas Chomont, a leading researcher at the University of Montreal.

Topics covered during the webinar included:

  • What are researchers talking about when they say “cure”?
  • What kind of progress is being made toward a cure for HIV?
  • How can we talk about HIV cure to our communities?
  • What do we need to know before AIDS 2016?

SLIDES / AUDIO

For information on other CUREiculum webinars, visit here.

Avac Event

Webinar: The Dapivirine Ring – What’s the story?

A joint STRIVE and AVAC webinar.

For the first time, two large-scale studies have confirmed modest efficacy for a microbicide to prevent HIV. The vaginal ring is made of a flexible silicone material infused with dapivirine, a potent ARV that works by preventing the virus from making copies of itself. The ring enables the drug to be released slowly over time, directly to the site of potential infection, with low absorption elsewhere and is designed to be worn for up to three months at a time.

In this webinar, we discussed:

  • Why were the ring results greeted with disappointment by some and joy by others?
  • What plans are there to introduce the ring into prevention programs and how will it sit within the roll-out of PrEP?
  • What role can/should such biomedical tools play within the overall response to HIV?

Presenter:

Rebekah Webb is an HIV prevention research advocate based in the UK. She has been a campaigner for new prevention options for women since 2002 and was the European Coordinator for the Global Campaign for Microbicides until she began freelancing. Rebekah now works regularly with AVAC, the European AIDS Treatment Group (EATG) and STOPAIDS to advance political commitment to HIV prevention efforts in Europe.

Recommended Background Reading:

Avac Event

CUREiculum Webinar: Stakeholder Engagement

Avac Event

CUREiculum Webinar: Early ART

Early ART does not cure HIV. However, researchers globally are looking to understand why some HIV-positive individuals can achieve a temporary remission while others rebound quickly after stopping treatment. This module gave an overview of the current research landscape and place early ART research in the larger framework of the HIV cure research agenda. The webinar was led by Dr. Jintanat Ananworanich, MD, PhD.

Avac Event

2017 Fellows Informational Call

Listen here for a recording of the Fellows Program informational call.

Avac Event

Webinar: The Ethics of Cure Research

The HIV cure research field presents new challenges to study conduct, design, risk and a host of other issues — scientific, biological, social, ethical and regulatory — that many stakeholders are grappling with. This module will begin to unpack some of the ethical issues associated with HIV cure research.

Avac Event

Webinar: Pediatric HIV Cure Research

The case of the “Mississippi child” has intrigued scientists since the case was first announced as “cured” in 2013. After the Mississippi child rebounded after two years of remission little has been mentioned about pediatric HIV cure research in the media. This webinar answered the essential questions about the state of the research and discussed the opportunities and challenges in pursuing curative strategies in pediatric populations.

Materials from additional webinars in the Cureiculum series are available, click here.

Avac Event

Webinar: Operationalizing Ethics – A focus on informed consent

Professor Gail Henderson, PhD describes what regulatory processes are in place to keep participants in HIV cure research safe. In this webinar, she described the relationship between informed consent and ethical research, identified challenges of discussions around risks and benefits and provided points of considerations for the informed consent process.

Materials from additional webinars in the Cureiculum series are available, click here.

Avac Event

Before the Pen Hits the Pad: PrEP Education for Health Care Providers

The US CDC estimates that nearly 500,000 women in the US could benefit from using PrEP. But women’s uptake of PrEP is small compared to men’s because most women who might want it have never even heard of it. One of the most effective ways to raise most women’s awareness of PrEP is to get their health care providers (usually family planning clinics) talking to them about PrEP.

In this webinar we explored the education that needs to be done among those health care providers to make this happen and what is being done to be prioritize it, especially by federal agencies, state and local health departments.

Avac Event

New Data, New Questions: An Update on Hormonal Contraception and HIV

AVAC, in collaboration with ICW East Africa, hosted a webinar on the most recent data regarding hormonal contraception and HIV. The call, moderated by ICW-EA, featured a number of resource people to address the following:

  • A summary of the recently released systematic review on hormonal contraception and HIV.
  • Updates from the World Health Organization on actions planned and underway related to this important question.
  • Reflections from investigators involved in the ongoing ECHO trial that is studying three different contraceptive methods and their impact on the risk of acquiring HIV.
  • The civil society view from the HC-HIV Advocacy Working Group—an issue-focused platform of African women advocates and their allies, convened by AVAC and ICW-EA.

Webinar Recording

A recording of the webinar is available here. The slides are available to download as well—click here.

Background

For background on this topic, please see the following resources: